Gene coexpression analysis of synthetic brain samples accurately predicts differential expression among CNS cell classes. To illustrate the premise of our approach, we aggregated SC RNA-seq data from adult human brain 1 to create synthetic samples that mimic the heterogeneity of intact tissue (Fig. 1a ). We performed unsupervised It is widely assumed that cells must be physically isolated to study their molecular profiles. However, intact tissue samples naturally exhibit variation in cellular composition, which drives covariation of cell-class-specific molecular features. By analyzing transcriptional covariation in 7,221 intact CNS samples from 840 neurotypical individuals, representing billions of cells, we reveal the core transcriptional identities of major CNS cell classes in humans. By modeling intact CNS transcriptomes as a function of variation in cellular composition, we identify cell-class-specific transcriptional differences in Alzheimer's disease, among brain regions, and between species. Among these, we show that PMP2 is expressed by human but not mouse astrocytes and significantly increases mouse astrocyte size upon ectopic expression in vivo, causing them to more closely resemble their human counterparts. Our work is available as an online resource (http://oldhamlab.ctec.ucsf.edu/) and provides a generalizable strategy for determining the core molecular features of cellular identity in intact biological systems.
I dentifying the molecular features that define cellular identities is a fundamental goal of biological research. Consequently, several 'bottom-up' methods have been developed to isolate cells for molecular profiling, including fluorescence-activated cell sorting (FACS), immunopanning (IP), and sorting of single cells (SC) or nuclei (SN). Although these methods are readily applied to many biological systems, their applicability to the adult human CNS is limited by technical factors and practical considerations. For example, FACS, IP, and SC typically require fresh tissue and have therefore been mostly limited to surgical samples from a handful of CNS regions and individuals [1] [2] [3] . SN 4,5 is compatible with frozen tissue but, like SC, suffers from technical noise caused by tissue dissociation, nucleus or cell capture, cDNA preamplification, and stochastic transcript coverage 6 . Furthermore, there is a trade-off between sequencing depth and the number of nuclei or cells that can be analyzed.
The adult human CNS is large, heterogeneous, and difficult to dissociate due to extensive myelin. It consists of ~170 billion cells, about half of which are neurons 7 . The remaining cells consist mostly of oligodendrocytes, astrocytes, and microglia, which are collectively referred to as glia. Identifying transcriptional differences among neuronal and glial subtypes is an important goal, as heterogeneity within CNS cell classes is incompletely understood. However, it is equally important to understand what CNS cell subtypes have in common. For example, is there a core set of genes whose expression is shared among all neurons? All astrocytes? Etcetera. Answering these questions will fill critical gaps in our understanding of CNS cell biology, produce novel experimental and analytical strategies, and provide important insights into the cellular origins of CNS pathologies.
Most studies of human CNS transcriptomes analyze intact postmortem samples. Because these samples are heterogeneous and cells must be destroyed to extract RNA, it is often assumed that these data sets contain no information about the cellular origins of gene expression. However, it is axiomatic that intact tissue samples from any biological system will exhibit variable cellular composition. Therefore, when many intact tissue samples are analyzed, genes expressed with the greatest sensitivity and specificity in the same cell class should appear highly correlated, as their expression levels depend primarily on the proportion of that cell class in each sample 8 . In support of this reasoning, which has motivated numerous in silico deconvolution strategies [9] [10] [11] [12] [13] [14] [15] , we previously discovered highly reproducible gene coexpression modules in microarray data from intact human brain samples that were significantly enriched with markers of major CNS cell classes 16 . These findings were replicated in studies of intact CNS transcriptomes from mice 17 , rats 18 , zebra finches 19 , macaques 20 , and humans 21 .
Gene coexpression modules corresponding to major cell classes are therefore robust and predictable features of CNS transcriptomes derived from intact tissue samples. Furthermore, the same genes consistently show the strongest affinities for these modules, offering substantial information about the molecular correlates of cellular identity 16 . Over the past decade, thousands of intact, neurotypical human samples from every major CNS region have been transcriptionally profiled. These data provide an unprecedented opportunity to determine the core transcriptional features of cellular identity in the human CNS from the top down by integrating cell-class-specific gene coexpression modules from many independent data sets.
for neurons was compressed ( Fig. 2a-d) , likely reflecting neuronal heterogeneity among CNS regions. Genome-wide estimates of expression fidelity for major cell classes are provided in Supplementary  Table 3 and on our web site (http://oldhamlab.ctec.ucsf.edu/).
To further explore how estimates of gene expression fidelity derived from intact tissue relate to gene expression in individual cells, we analyzed droplet-based SN RNA-seq data from neurotypical adult human brains. Habib et al. 4 analyzed 14,963 nuclei from cortical and hippocampal samples from five individuals, detecting a median of 529 unique genes per nucleus. Lake et al. 34 analyzed 35,289 nuclei from cortical and cerebellar samples from six individuals, detecting a median of 719 unique genes per nucleus. In general, expression patterns of high-fidelity genes were conserved in SN RNA-seq data ( Fig. 2e ). We extended these comparisons by examining concordance among top high-fidelity genes and top differentially expressed genes for each cell class from each SN study ( Fig. 2f-i) . For all comparisons, overlap was highly significant (P < 10 −15 ), but less so for neurons, which likely reflects differences among CNS regions analyzed in each study. Given the shallow coverage that characterizes droplet-based SC and SN methods, we hypothesized that discordant results might also represent type-II errors in SN RNA-seq data (that is, dropouts). To test this hypothesis, we compared expression levels of discordant and concordant genes. For all cell classes, discordant genes were expressed at significantly lower levels than concordant genes in our collection of 7,221 intact human CNS samples ( Fig. 2f-m ). Furthermore, discordant genes were detected far less frequently than concordant genes in single nuclei from both studies ( Supplementary Fig. 3 ). For an orthogonal perspective, we analyzed expression of discordant genes in cell classes purified by IP from adult human temporal lobe surgical resections 3 . In all cases, gene expression fidelity correctly predicted the dominant cellular source of mRNA ( Fig. 2n-q) . These results underscore the sparse nature of current droplet-based SN RNA-seq data. Comparisons of fidelity and differential expression results for all genes are reported in Supplementary Table 4 .
High-fidelity genes reveal the core transcriptional identities of major CNS cell classes in humans. The genes with the highest expression fidelity for major CNS cell classes were consistently coexpressed across regions and technology platforms ( Supplementary  Fig. 4 ). We visualized the top 50 genes ranked by expression fidelity for each cell class to compare their expression levels, mutation intolerance, literature citations, cellular localization, and protein-protein interactions ( Fig. 3a-d ). Overall, expression levels of high-fidelity genes were highest for neurons and lowest for microglia ( Fig. 3a-d) . However, each cell class had a wide range of expression levels for high-fidelity genes, suggesting parallel regulatory mechanisms and/ or differential transcript stability.
To assess the tolerance of high-fidelity genes for loss-of-function mutations, we analyzed data from the Exome Aggregation Consortium, which summarizes the prevalence of coding mutations in ~61,000 human exomes 35 . Unexpectedly, high-fidelity neuronal genes were significantly less tolerant of loss-of-function mutations than high-fidelity glial genes ( Fig. 3a-d ). We then searched PubMed to determine whether high-fidelity genes have been studied in their respective cell classes ( Fig. 3a-d) . Notably, many searches returned no citations, highlighting critical gaps in our understanding of CNS cell biology. For example, the top microglial gene (amyloid beta precursor protein binding family B member 1 interacting protein, or APBB1IP) is unstudied in microglia.
We also examined the cellular localization of proteins 36 encoded by high-fidelity genes. Among those shown in Fig. 3a-d , membrane localization was reported for 33 proteins in astrocytes, 22 in oligodendrocytes, and 30 in microglia, but only 13 in neurons. This result may reflect the homeostatic functions of glia as regulators of extracellular CNS environments. More generally, the nonrandom gene coexpression analysis to identify those gene coexpression modules in each synthetic data set that were maximally enriched with published markers 22, 23 of astrocytes, oligodendrocytes, microglia, or neurons ('cell-class modules'; Fig. 1a ). In principle, expression variation in a cell-class module primarily depends on the representation of that cell class in each sample. Mathematically, the vector that explains the most variation in a coexpression module is its first principal component, or module 'eigengene' (Fig. 1a) 24 . This reasoning suggests that a cell-class module eigengene should approximate the relative abundance of that cell class in each sample. Because the precise cellular composition of each synthetic sample was known, we tested this hypothesis and found that actual cellular abundance was nearly indistinguishable from that predicted by cell-class module eigengenes ( Supplementary Fig. 1a ).
To determine the affinity of each gene for each cell-class module, we calculated the weighted gene coexpression network analysis measure of intramodular connectivity, k ME 25 . k ME is defined as the Pearson correlation between the expression pattern of a gene and a module eigengene. In the special situation of a cell-class module, k ME therefore quantifies the similarity between the expression pattern of a gene and the relative abundance of that cell class in each sample. Because each sample is a heterogeneous mixture of cells, high k ME for a cell-class module suggests that expression of the gene in that cell class is sensitive and specific. We tested this hypothesis by performing differential expression analysis of SC RNA-seq data for each cell class, restricting our analysis to exactly the same cells used to construct the synthetic samples. As shown in Fig. 1b , the genes that were most upregulated in a cell class also had the highest k ME values for the corresponding cell-class module. We obtained nearly identical results by aggregating SC RNA-seq data from adult mouse brain 26 (Supplementary Fig. 1b,c) . These findings demonstrate that gene coexpression analysis of intact CNS samples can determine which genes are most differentially expressed among CNS cell classes. More generally, our results suggest that it is not always necessary to physically isolate cells in order to ascertain their defining transcriptional features.
Integrative gene coexpression analysis of intact tissue samples reveals consensus transcriptional profiles of major CNS cell classes in humans.
To determine consensus transcriptional profiles of human CNS cell classes, we analyzed 7,221 CNS transcriptomes from 840 neurotypical adult humans by combining data from eight studies 21, [27] [28] [29] [30] [31] [32] [33] and one resource (http://www.brainspan.org/). These data were generated from intact postmortem tissue samples using diverse technology platforms ( Supplementary Table 1 ) and collectively represent billions of cells. Each sample was assigned to one of 19 broad neuroanatomical regions, resulting in 62 regional data sets ( Fig. 1c ). After data preprocessing and quality control, each data set consisted of ≥ 25 samples (median: 76; Supplementary Table 1 ). For each data set, we performed unsupervised gene coexpression analysis and identified the module that was maximally enriched with published markers 22, 23 of astrocytes, oligodendrocytes, microglia, or neurons ( Fig. 1d and Supplementary Table 2 ). Principal component 1 (PC1) of these modules was used to estimate the relative abundance of each cell class over all samples and to calculate genome-wide k ME values ( Fig. 1e,f ). Finally, we combined k ME values for significant cell-class modules (Supplementary Table 2 ) from all 62 data sets, producing a single value (z-score) for each gene that quantified its global expression fidelity for each cell class ( Fig. 1g ). Notably, estimates of fidelity were highly robust to the choice of gene set used for enrichment analysis (especially for glia; Supplementary Fig. 2 ). Canonical markers consistently had high fidelity for the expected cell class and low fidelity for other cell classes ( Fig. 2a-d) . Highfidelity genes were also significantly and specifically enriched with expected cell-class markers from multiple independent studies ( Fig. 2a-d ). Compared to glia, the distribution of expression fidelity Acquire and preprocess 62 regional human CNS gene expression data sets: n = 7,221 samples after quality control unsupervised gene coexpression analysis of synthetic samples revealed CNS cell-class modules that were highly enriched with markers of major cell classes. Cell-class module membership strength (k ME ) was calculated for all genes. Bottom right: using the same cells that were selected to create synthetic samples, single-cell differential expression analysis was performed for all genes with respect to each cell class. b, k ME values for synthetic cell-class modules accurately predicted the results of differential expression analysis for each cell class (n = 10 synthetic data sets; 'up' and 'down' denote up-and downregulated genes for each cell class Table 2 ).
(e) For each data set, the module that was most significantly enriched with markers of a given cell class (Supplementary Table 2 ) was summarized by its first principal component (PC1, or module eigengene). (f) Cell-class module eigengenes were used to calculate the similarity between cellular abundance and genome-wide expression patterns (k ME ) over all samples in each data set. (g) Genome-wide k ME values for significant cell-class modules from all data sets were combined to yield a global measure of expression fidelity for each gene with respect to each cell class. Schematic: a gene has high fidelity for a cell class if its expression is sensitive (it is consistently expressed by members of that cell class) and specific (it is not expressed by members of other cell classes). Human brain images (a,c) and cell-class schematics (a,g) adapted from Servier Medical Art under a Creative Commons Attribution 3.0 Unported License (https://creativecommons.org/licenses/by/3.0/legalcode). Color and dimensions were modified. Edges of boxplots denote interquartile ranges (25th-75th percentile) with whiskers denoting 1.5 times the interquartile range and black line denoting the median value; notches denote 1.58 times the interquartile range divided by the square root of the number of samples. SLC1A3  GJA1  SLC1A2  AQP4  SOX2  SOX9  GLUD1  ALDH1L1  GLUL   GFAP   CNP  PLP1  MOG  SYN1  SNAP25  AIF1  SYT1   0   50   100 Astrocyte expression fidelity (z−score)
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Localization The top 50 genes ranked by consensus expression fidelity for astrocytes, oligodendrocytes, microglia, or neurons. Expression levels represent averages of mean percentile ranks for all regional data sets in which gene data were present. Mutation intolerance data were obtained from the Exome Aggregation Consortium 35 . PubMed citations were obtained by queries with gene symbol and cell class (for example, gene symbol and 'astrocyte'). Cellular localization data were extracted from COMPARTMENTS 36 . Predicted protein-protein interactions (PPI) were obtained from STRING 37 . A link is shown if the combined score between two proteins was > 350. The probability of observing the number of depicted links by chance was determined by resampling (n = 100,0000 random samples of 50 genes). LoF, loss-of-function mutation. e-h, Novel markers of human astrocytes (PON2), oligodendrocytes (DBNDD2), microglia (APBB1IP), and neurons (CELF2) in adult human dorsolateral prefrontal cortex (DLPFC; e: layer (L)5/6; f,g: white matter; h: L2/3). Immunostaining was repeated at least twice on independent samples with similar results. Arrowhead, cell in inset. Scale bar, 50 μ m; inset, 10 μ m.
using the top 10 or top 50 high-fidelity genes) provided only modest performance improvements (unless otherwise stated, subsequent models used the top 10 high-fidelity genes). Third, prediction accuracy depended strongly on technology platform (P < 10 −7 , ANOVA) but not CNS region (P = 0.92, ANOVA). Among microarrays, older platforms fared substantially worse than newer platforms, while RNA-seq generally outperformed all microarrays. Despite their simplicity, our models explained > 50% of expression variation, averaged over all data sets, for ~2,000 genes ( Fig. 5c ). Over all genes, the average amount of expression variation explained by our models followed a sigmoid function ( Fig. 5c ). We benchmarked model performance against the maximal explanatory power of any four predictors by using PC1-PC4 from each data set as covariates for multiple regression. On average, PC1-PC4 explained 49.6% of total gene expression variation over all data sets ( Fig. 5b ). Thus, modeling gene expression in the human CNS as a function of neuron, astrocyte, oligodendrocyte, and microglia abundance achieved, on average, 72.0% of the maximal explanatory power for all data sets and 80.1% for RNAseq data sets ( Fig. 5b) .
We reasoned that model performance for RNA-seq might exceed that for microarrays as the latter have many probes for transcripts unlikely to be expressed in the CNS. We therefore stratified genes by expression levels and examined model performance. As expected, predictive power decreased at lower expression levels, with the sharpest decline between the third and fourth quartiles ( Fig. 5d ).
We next explored how transcriptional variation related to variation in the abundance of individual cell classes, sex, and age. Neuronal abundance explained more transcriptional variation than glial abundance ( Fig. 5e ). After controlling for variation in the abundance of major cell classes, model performance did not substantially improve by including sex or age as covariates ( Fig. 5e ). We further explored this topic by correlating estimated cellular abundance with age in 32 CNS data sets. Neuronal and oligodendroglial abundance were negatively correlated with age, while astrocytic and microglial abundance were positively correlated ( Fig. 5f ). These results suggest that age-related changes in gene expression in bulk CNS transcriptomes are primarily driven by age-related changes in cellular composition.
Gene expression modeling applications. The ability to predict gene expression in transcriptomes from intact CNS samples has important implications. We illustrate the versatility of this approach through comparative analysis of gene expression models in disease, among CNS regions, and between species. Application 1: contextualizing disease genes and modeling gene expression in pathological samples. We asked whether genes associated with CNS diseases 39 are enriched among genes primarily expressed by astrocytes, oligodendrocytes, microglia, or neurons ( Fig. 6a,b ). Clustering select CNS diseases by enrichment P values revealed several notable findings. First, genes associated with neurodegenerative disorders, except amyotrophic lateral sclerosis, were most enriched among genes expressed by microglia and astrocytes. Second, genes associated with neurodevelopmental disorders, epilepsy, and psychiatric disorders were most enriched among genes expressed by astrocytes and neurons. Third, genes expressed by astrocytes consistently showed the greatest enrichment with candidate CNS disease genes.
Beyond broad associations between diseases and cell classes, gene expression modeling can also reveal which cell classes are most likely to express candidate disease genes. For example, we modeled gene expression for Alzheimer's diseases (AD) risk genes as a function of neuronal, oligodendroglial, astrocytic, and microglial abundance in transcriptomes from intact neurotypical adult human temporal cortex ( Fig. 6c ). Expression levels of early-onset AD distributions of cellular localizations suggest that high-fidelity genes are expressed as proteins in their corresponding cell classes. Indeed, protein-protein interactions 37 among high-fidelity gene products for each cell class revealed significantly more interactions than expected by chance ( Fig. 3a-d ).
Because high-fidelity genes should encode optimal biomarkers, we searched for high-fidelity genes in the Human Protein Atlas (http://www.proteinatlas.org) to identify novel reagents for labeling human CNS cell classes. We identified validated antibodies for PON2 (astrocytes), DBNDD2 (oligodendrocytes), APBB1IP (microglia), and CELF2 (neurons; highlighted in Fig. 3a-d ). Dual immunostaining with canonical markers revealed almost perfect concordance in human frontal cortex ( Fig. 3e-h and Supplementary Fig. 5 ).
Gene coexpression analysis of intact tissue samples reveals the core transcriptional features of diverse CNS cell classes.
Variation among intact tissue samples can also reveal transcriptional features of less abundant human CNS cell classes. Following the general strategy outlined in Fig. 1 , we calculated genome-wide expression fidelity for human cholinergic neurons, midbrain dopaminergic neurons, endothelial cells, ependymal cells, choroid plexus cells, mural cells, oligodendrocyte progenitor cells, and Purkinje neurons ( Fig. 4 , Supplementary Fig. 6 , and Supplementary Table 3 ). This analysis correctly assigned high fidelity scores for canonical markers of these cells. For example, choline acetyltransferase (CHAT), the high-affinity choline transporter (SLC5A7), and the vesicular acetylcholine transporter (VACHT) all ranked within the top ~0.2% for genome-wide cholinergic neuron expression fidelity, while claudin 5 (CLDN5), tyrosine kinase with immunoglobulin-like and EGFlike domains 1 (TIE1), and platelet and endothelial cell adhesion molecule 1 (PECAM1) all ranked within the top ~0.3% for genomewide endothelial cell expression fidelity ( Supplementary Table 3 ). High-fidelity genes were significantly and specifically enriched with published markers of each cell class from multiple independent studies; furthermore, novel markers predicted by our analysis were validated by in situ hybridization in adult mouse brain 38 ( Fig. 4 and Supplementary Fig. 6 ). Table 2 and Supplementary Fig. 4 ) suggested that transcriptomes of intact CNS samples could be modeled as a function of cellular abundance. We explored this topic systematically by performing multiple linear regression in 47 CNS data sets with ≥ 40 samples to determine how much expression variation in a shared set of ~9,600 genes could be explained by variation in the abundance of neurons, astrocytes, oligodendrocytes, and microglia. To estimate the relative abundance of each cell class in each data set, we summarized the expression patterns of high-fidelity genes (Fig.  5a ). To avoid circularity, we used a leave-one-out cross-validation strategy to redefine high-fidelity genes for each data set by recalculating expression fidelity for each cell class using the remaining 46 data sets (as in Fig. 1c -g). More aggressive exclusion criteria (for example, excluding 90% of data sets before redefining high-fidelity genes) produced nearly identical results ( Supplementary Fig. 7 ). Before modeling, each data set was downsampled (n = 40) to facilitate comparisons of results; this process was performed iteratively to ensure robustness ( Fig. 5a ).
High-fidelity genes enable predictive modeling of gene expression in transcriptomes from intact tissue samples. The reproducibility of gene coexpression modules corresponding to major cell classes (Supplementary
Implementing this strategy, we obtained several noteworthy results ( Fig. 5b ). First, using only one gene (with the highest fidelity) as a surrogate for each cell class, our models explained 32.2% of total transcriptional variation averaged over all data sets and up to ~50% in some data sets (versus ~0.1% for permuted data). Second, increasing the number of gene surrogates per cell class (for example, Nissl P < 10 -10 Human consensus n = 18,394 genes
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Fig. 4 | Variation among intact tissue samples reveals transcriptional signatures of human cholinergic neurons, midbrain dopaminergic neurons, endothelial cells, and ependymal cells. a-d, Top
: high-fidelity genes for each cell class (top 10 are shown) are consistently coexpressed in independent data sets ( Supplementary Table 1 ). Middle: consensus gene expression fidelity distributions for each cell class with canonical markers of major cell classes labeled in green (neurons), red (astrocytes), blue (oligodendrocytes), and black (microglia). Gene expression fidelity distributions for published sets of markers (Al, A2, O1, O2, M1, M2, N1, N2, cholinergic (C) 1, C2, dopaminergic (D) 1, D2, endothelial (E) 1, E2, ependymal (Ep) 1, and Ep2; Methods) were crossreferenced with high-fidelity genes (top three percentiles). Gray shading indicates significant enrichment (one-sided Fisher's exact test). Note that E2 and Ep1 were gene sets used for module enrichment analysis (Supplementary Table 2 ). The number of independent samples used to calculate fidelity for each gene is provided in Supplementary Table 3 . Bottom: mouse hybridization data from the Allen Mouse Brain Atlas 38 for high-fidelity genes in dorsal striatum (a), ventral midbrain (b), cortex (c), and lateral ventricle (d). Scale bar, 200 μ m; inset, 500 μ m. Violin plots outline the Gaussian kernel probability density and are trimmed to the range of the data. Agilent, Agilent microarrays; BF, human basal forebrain; STR, striatum; MID, midbrain; OCX, occipital cortex.
risk genes APP and PSEN1 were mostly explained by variation in neuronal and oligodendroglial abundance, respectively. In contrast, expression levels of late-onset AD risk genes APOE and TREM2
were mostly explained by variation in astrocytic and microglial abundance, respectively. These results were consistent across 47 CNS data sets ( Fig. 6d ). for ~9,600 genes whose expression levels were modeled as a function of inferred astrocyte, oligodendrocyte, microglia, and neuron abundance in each of 47 regional data sets (subset to 40 samples; values are mean ± 2 s.e.m., 10 iterations). c, Mean adjusted r 2 values for individual genes from b over the 47 data sets. Grey envelope: Loess smoothed confidence interval (± 2 s.e.m., 10 iterations). d, Mean adjusted r 2 values for genes from b grouped by mean expression quartiles (each point is one data set). e, Mean adjusted r 2 values for seven different models, restricted to data sets with sex and age information: GSE46706, GTEx, GSE11882, and GSE25219 ( Supplementary Table 1 49 . c, Linear regression modeling results in TCX from Allen Brain Institute (ABI; that is, one data set consisting of 465 samples) for four AD risk genes. d, Modeling results for genes from c in 47 data sets (≥ 40 samples). Arrows denote modeling results featured in c. e, Top 10 high-fidelity genes were used to estimate the relative abundance of neurons, astrocytes, microglia, and oligodendrocytes in DLPFC from control and AD 41 ( Fig. 5a ; n = 95 control and 95 AD biologically independent tissue samples; two-sided Wilcoxon rank-sum test). Data from GSE44770. Edges of boxplots denote interquartile ranges (25th-75th percentile) with whiskers denoting 1.5 times the interquartile range and black line denoting the median value; notches denote 1.58 times the interquartile range divided by the square root of the number of samples. f, Gene expression modeling in three data sets [40] [41] [42] reveals consistent cell-class-specific expression changes in AD after controlling for differences in cellular abundance (P < 0.05 based on 1,000 permutations of sample labels). Shown are the total number of genes that were significantly altered for each cell class in all three data sets. g, Examples of two genes that are upregulated in AD neurons (top 41 ; bottom 42 ).
( Supplementary Fig. 11 and Supplementary Tables 1 and 7) . Expression fidelity was significantly correlated between mice and humans for each cell class, with the greatest similarity for neurons ( Fig. 8a ). We note that evolutionary conservation of neuronal expression fidelity relative to glia is mirrored at the protein level ( Fig. 3a-d ). These findings may indicate that neurons are under greater evolutionary constraint than glia. We applied stringent criteria and identified 50 genes predicted to be 'ON' in human CNS cell classes and 'OFF' in the corresponding mouse CNS cell classes, as well as six genes with the opposite pattern ( Fig. 8b and Supplementary Table 8 ). Roughly 85% of these differences were predicted to occur in glia ( Fig. 8b ). We also analyzed 476 outgroup samples from chimpanzee and macaque brains ( Supplementary Table 1 ). Of the 50 genes predicted to be expressed in human but not mouse cell classes, 29 were significantly associated with the same cell class in at least one primate data set; conversely, of the six genes with the opposite pattern, none was significantly associated with the same cell class in any primate data set ( Supplementary Table 8 ). For example, expression variation of MRVI1 was largely explained by astrocyte abundance in primates, but not mice ( Fig. 8b and Supplementary Fig. 12a,b ). Conversely, expression variation of PLA2G7 was largely explained by astrocyte abundance in mice, but not primates ( Fig. 8b and Supplementary  Fig. 12a,b ). Single-molecule fluorescent in situ hybridization confirmed that expression of MRVI1 and PLA2G7 is specific to human and mouse astrocytes, respectively ( Supplementary Fig. 12c,d) .
To demonstrate the ability of our analyses to deliver functional insights into the unique biology of human brains, we focused on the unexplained fact that human astrocytes are much larger than mouse astrocytes (and nonhuman primate astrocytes) 43 . This phenotype has important implications for neuronal function, since one human astrocyte can encompass ~2 million synapses, versus ~100,000 synapses for one mouse astrocyte 43 . We reasoned that genes expressed by human but not mouse astrocytes might contribute to this phenotype. We were particularly intrigued by peripheral myelin protein 2 (PMP2; Fig. 8b ), which encodes a fatty-acid binding protein that maintains membrane lipid composition in Schwann cells 44 . In the human CNS, PMP2 expression was extremely high (mean percentile: 96.2) and largely explained by astrocyte abundance, while in the mouse CNS, Pmp2 expression was effectively absent (mean percentile: 11.2) and unrelated to astrocyte abundance ( Fig. 8b-d ). Furthermore, independent RNA-seq data from human, chimpanzee, macaque, and mouse neocortex 45 revealed a monotonic increase in PMP2 expression from mouse to human ( Fig. 8e ).
Immunostaining revealed widespread PMP2 in human neocortical astrocytes but no PMP2 in mouse neocortex ( Fig. 8f ), despite robust expression by Schwann cells ( Supplementary Fig. 12e ). To test whether PMP2 could increase mouse astrocyte size in vivo, we delivered a viral construct expressing PMP2 under an astrocyte-specific promoter to neonatal mouse brains and analyzed the morphology of transduced astrocytes after 42 d ( Fig. 8g ). Forced expression of PMP2 in mouse astrocytes significantly increased their maximum diameter and number of primary processes (Fig. 8h ,i). The increase in maximum diameter corresponded to an increase in mouse astrocyte volume of ~50% (assuming sphericity). We repeated this experiment with a different viral construct and obtained nearly identical results ( Supplementary Fig. 12f ). To our knowledge, these data provide the first molecular explanation for morphological differences between human and mouse astrocytes. More generally, our findings illustrate how variation among intact tissue samples can predict cell-class-specific transcriptional features with important functional implications for human neurobiology.
Discussion
We have described an approach to reveal the core transcriptional features of cellular identity via integrative gene coexpression Compared to control human brain samples, AD samples should contain fewer neurons and proportionately more glia. We tested this hypothesis by using expression patterns of high-fidelity genes to infer the relative abundance of neurons, astrocytes, microglia, and oligodendrocytes in three gene expression data sets from intact postmortem brain samples of control and AD subjects [40] [41] [42] . We observed a highly significant decrease in neuronal abundance in AD in all data sets ( Fig. 6e and Supplementary Fig. 8a,b ). In two of three data sets, there were significant increases in the relative abundance of astrocytes and microglia in AD, with similar trends in the third ( Fig. 6e and Supplementary Fig. 8a,b) . Notably, there were no significant differences in oligodendrocyte abundance between control and AD in any data set ( Fig. 6e and Supplementary Fig. 8a,b) , and simulations revealed that estimates of cellular abundance were robust to a wide range of transcriptional dysregulation among genes used to derive these estimates ( Supplementary Fig. 9 ). This strategy can help determine whether variable cellular composition is associated with diverse CNS disorders.
Because AD brain samples have fewer neurons and proportionately more astrocytes and microglia than control brains, differential expression analysis of intact tissue samples reveals downregulation of neuronal transcripts and upregulation of astrocytic and microglial transcripts. However, predictive modeling can identify cellintrinsic transcriptional differences between control and AD samples that are independent of changes in cellular composition. This strategy is analogous to that of Kuhn et al. 11 , except that we used expression patterns of high-fidelity genes to estimate cellular abundance. Unexpectedly, after controlling for differences in cellular composition between control and AD brains, we identified many genes that were consistently upregulated in AD neurons ( Fig. 6f and Supplementary Table 5 ). These genes did not include canonical AD risk genes ( Supplementary Fig. 8c ), but rather genes involved in protein ubiquitination, catabolism, proteasome degradation, and mitochondrial function ( Supplementary Fig. 8d ). Examples are shown in Fig. 6g and Supplementary Fig. 8 .
Application 2: identifying transcriptional differences in major cell classes among CNS regions. We recalculated expression fidelity for each CNS region with ≥ 3 data sets and clustered each cell class ( Fig. 7a-d ). Regional differences in expression fidelity were greatest for neurons, with bifurcation between cortical and subcortical structures ( Fig. 7d,e ). In contrast, oligodendrocyte expression fidelity was very similar among brain regions ( Fig. 7b,e ). Comparatively, microglia and astrocytes exhibited more regional variation in expression fidelity than oligodendrocytes, but less than neurons ( Fig. 7a ,c,e).
We developed a conservative strategy to identify binary expression differences in major cell classes among human brain regions (Fig. 7f,g and Supplementary Table 6 ). Many genes were predicted to distinguish regional subpopulations of neurons, but we found no evidence for binary expression differences among regional subpopulations of microglia or oligodendrocytes ( Fig. 7h and Supplementary Fig. 10 ). However, we did predict binary expression differences among regional subpopulations of human astrocytes ( Fig. 7h ,i). For example, CHRDL1 was predicted to be expressed by astrocytes in frontal cortex and striatum, but not in diencephalon or midbrain ( Fig. 7i-k) . To validate this prediction, we performed single-molecule fluorescent in situ hybridization for Chrdl1 and Aldh1l1 in mouse cortex and thalamus. Aldh1l1 is expressed ubiquitously by astrocytes 22 and was detected in both regions ( Fig. 7j-l) . Expression of Chrdl1 colocalized with Aldh1l1 in mouse cortex but not thalamus ( Fig. 7l ), as predicted. DI   OCX   PCX   TCX   FCX   LIM   HIP  STR  AMY  MID  DI  OCX  PCX  TCX  FCX  LIM   AMY   PCX   TCX   OCX   FCX   LIM   HIP   STR   DI   MID   AMY  PCX  TCX  OCX  FCX  LIM  HIP  STR  DI  MID   AMY   STR   HIP   DI   MID   LIM   FCX   OCX   PCX   TCX   AMY  STR  HIP  DI  MID  LIM  FCX  OCX  PCX  TCX   AMY   HIP   STR   DI   MID   OCX   PCX   TCX   FCX   LIM   AMY  HIP  STR  DI  MID  OCX  PCX  TCX  FCX Supplementary Table 1 for numbers of data sets and samples per region). e, Distributions of correlations in a-d (n = 10 regions). Violin plots outline the Gaussian kernel probability density and are trimmed to the range of the data. f, Workflow for predicting regional expression differences in specific cell classes. Significance threshold: P < 2.67 × 10 −8 (Bonferroni correction for total number of gene models). g, Schematic of analyzed brain regions. h, Total number of region-specific genes conservatively predicted for each cell class. i, Genes predicted to be expressed by human astrocytes in restricted brain regions. j, Modeling of CHRDL1 (candidate from i) and ALDH1L1 (positive control) as a function of inferred astrocyte abundance in example data sets (FCX and DI from ABI; see Supplementary Table 1 for sample sizes). k, Linear regression modeling results for same genes in three data sets (ABI, GTEx, and GSE46706; Supplementary Table 1 Supplementary Table 1 ). SLC1A3 is predicted to be expressed by astrocytes in both species, and PMP2 is predicted to be expressed by astrocytes in humans but not mice. Ms, mouse; Hs, human. d, Astrocyte modeling results and mean expression percentiles for genes in c from all data sets (see Supplementary Tables 3 and 7 for the numbers of data sets and samples for each gene and species). Bar plots, mean values; error bars, s.e.m. e, SLC1A3 and PMP2 expression in an independent gene expression data set from human, chimpanzee, macaque, and mouse prefrontal and visual cortex 45 (n = 12 independent tissue samples for each species). Edges of boxplots denote interquartile ranges (25th-75th percentile) with whiskers denoting 1.5 times the interquartile range and black line denoting the median value; notches denote 1. and nucleus capture, (v) ability to estimate the relative abundance of cell classes among intact tissue samples, and (vi) ability to derive highly robust inferences about the core transcriptional features of cellular identity based on aggregate analysis of billions of cells.
Our approach also has limitations. False-positive associations can result from technical factors (for example, batch effects) or biological factors such as cellular colinearity. For example, we consistently observed that genes with high expression fidelity for oligodendrocytes had higher expression fidelity for microglia (and vice versa) than they did for astrocytes or neurons. Because oligodendrocytes and microglia are more abundant in white matter than gray matter 46 , variation in the ratio of white matter to gray matter in CNS samples drives covariation in the abundance of these cell classes and the genes they express. False-negative associations can result from technical factors such as limitations in dynamic range, transcriptome coverage, or probe failures, as well as biological factors like alternative splicing. Notwithstanding these limitations, the genes with the highest expression fidelity for major CNS cell classes are already remarkably stable.
Our approach also offers the ability to detect transcriptional signatures of less-abundant cell classes (for example, Fig. 4 and Supplementary Fig. 6 ). The ability to discern the transcriptional signature of a cell class in intact tissue samples depends on many factors, including its representation, the uniqueness and abundance of its transcripts, its stoichiometry with other cell classes, the technology platform, the algorithmic approach, and the sampling strategy 8 . Some of these factors can be optimized to improve sensitivity. Ultimately, we envision combining top-down and bottom-up strategies to fully deconstruct the transcriptional architecture of biological systems.
Gene expression fidelity estimates were highly robust to the choice of gene set used for enrichment analysis, but more so for glia than for neurons. This result indicates that neuronal diversity may require additional strategies to optimize estimates of neuronal expression fidelity, particularly on a regional basis. For example, the neuronal gene sets we used do not capture the transcriptional profile of cerebellar granule neurons, which is highly distinct 21, 29, 33 . To better account for neuronal diversity, future studies may combine neuron-subtype-specific gene sets for enrichment analyses.
Our results suggest that the functional identity of a cell class can be conceived as a vector of genes ranked by the fidelity with which they are expressed in that cell class relative to all other cells in the biological system of interest. An advantage of this framing is that it is inherently context-dependent. Beyond revealing novel biomarkers and cellular phenotypes, such definitions can provide 'molecular rulers' for measuring the validity of human cells derived in vitro for disease modeling and cell-replacement therapies. Furthermore, these definitions can be tested in de novo CNS transcriptomes for their ability to predict gene expression through mathematical modeling.
Multivariate analyses of CNS transcriptomes often use module detection and clustering methods or projection methods such as principal component analysis. Although these methods have produced many important insights, they are inherently descriptive and do not facilitate comparisons among independent data sets. Because the building block of any biological system is the cell and cells are distinguished by the genes they express, an alternative approach is to model gene expression as a function of cellular composition. We have shown how expression patterns of high-fidelity genes can be used for this purpose. The resulting models are highly robust, grounded in biology, easily compared among independent data sets, and capable of extracting cell-class-specific insights from intact tissue samples. Using this approach, we explored how predictive models of gene expression in transcriptomes from intact CNS samples can inform studies of aging, disease genes, pathological samples, regional heterogeneity, and species differences (Supplementary Note).
Our study is based on a simple idea: variation in cellular composition among intact tissue samples will drive covariation of transcripts that are uniquely or predominantly expressed in specific kinds of cells. Although we have focused here on gene expression, our approach can also be applied to other types of molecular data, thereby offering a generalizable strategy for determining the core molecular features of cellular identity in intact biological systems.
Online content
Any methods, additional references, Nature Research reporting summaries, source data, statements of data availability and associated accession codes are available at https://doi.org/10.1038/ s41594-018-0120-y.
Methods
Integrative analysis of human CNS transcriptomes. We obtained publicly available gene expression data from eight studies 21, [27] [28] [29] [30] [31] [32] [33] and one resource (http:// www.brainspan.org/) that profiled large numbers of postmortem CNS bulk tissue samples from neurotypical humans. Expression profiling was performed on six technology platforms, including RNA-seq and various commercial microarrays. Samples from each of the nine sources were separated into 62 data sets representing 19 major neuroanatomical regions. Each regional data set consisted of at least 25 samples, all of which came from adults (≥ 18 years). After removing outliers (see below), we analyzed a total of 7,221 transcriptomes ( Supplementary Table 1 ).
Data preprocessing and quality control. Preprocessing was performed from raw data when possible. Affymetrix microarray raw data (.CEL files) were downloaded from Gene Expression Omnibus (GEO) using the following accession IDs: GSE11882 28 , GSE25219 29 , GSE3790 27 , GSE45642 31 , and GSE46706 32 . Probe-level data from Affymetrix Exon 1.0 microarrays (GSE25219 and GSE46706) were summarized using the Robust Multi-Array (RMA) algorithm 50 at the gene level with Affymetrix Power Tools software (APT 1.15.2) and reverse log-transformed for further processing.
Affymetrix U133A and U133Plus2 microarray probes from GSE3790, GSE45642, and GSE11882 were pruned to eliminate nonspecific and mistargeted probes using the ProbeFilter R package (Dai et al. 51 ) with mask files 52 . After applying the mask files, only probe sets with at least seven remaining probes were retained for further analysis. Expression values were generated in R using the expresso function of the affy R package 53 with 'mas' settings and no normalization, followed by scaling of arrays to the same average intensity (200). For GSE45642, gene expression was not scaled, and technical replicates were removed (AMY samples restricted to site I; DLPFC samples restricted to site D; HIP and NUAC samples restricted to site M). Non-normalized Illumina microarray data were obtained from GEO for GSE36192 30 . Normalized expression data from GTEx, BrainSpan, and the Allen Brain Institute (ABI) were downloaded from their respective websites (http://www.gtexportal.org/, V6 data release; http://www. brainspan.org/, October 2013 data release; and http://human.brain-map.org/, March 2013 data release). For the RNA-seq data sets (GTEx and BrainSpan), RPKM gene expression values were used.
Sample information for data sets with GEO accession IDs was obtained using the GEOquery R package 54 , with the exception of hybridization batch information, which was extracted from the header information of Affymetrix .CEL files when available. Each of the 62 regional data sets was individually processed using the SampleNetwork R function 55 , which is designed to identify and remove sample outliers, perform data normalization, and adjust for batch effects 56 . We defined sample outliers as those that were more than 4 s.d. below the mean connectivity of all samples measured over all features (Z.K < -4). Iterative pruning was applied for each regional data set to remove all samples with Z.K < -4 (Supplementary Table 1 ). For non-normalized data (GSE11882, GSE3790, GSE45642, and GSE36192), quantile normalization 57 was then performed. If a batch effect was present (defined as a significant association between the first principal component of the expression data and a technical batch covariate), batch correction was performed using the ComBat R function 56 , which is implemented in SampleNetwork. For GTEx data, we detected a large batch effect due to center site. We therefore restricted our analysis to samples acquired by centers 'B1, A1' or 'C1, A1' . Lastly, before coexpression analysis, probes/genes that had zero variance across all samples were removed. For GTEx, we further restricted our analysis to 27,540 transcripts that were detected (≥ 0.1 RPKM) in at least 200 CNS samples. Supplementary Table 1 provides additional details on data preprocessing and quality control.
Unsupervised gene coexpression module detection. Gene expression data sets can exhibit different correlation structures due to biological and technical factors such
as cellular heterogeneity and sample size. This variability makes it difficult to apply a single set of parameters for coexpression analysis across many independent data sets. To address this challenge, we analyzed gene coexpression relationships in each regional data set in the R statistical computing environment (http://cran.us.rproject.org) using a four-step approach 58, 59 . First, pairwise biweight midcorrelations (bicor) were calculated for all possible pairs of probes/genes over all samples in each data set using the bicor function in the WGCNA R package 25 . Bicor is a robust correlation metric that is less sensitive to outliers than Pearson correlation but often more powerful than Spearman correlation 60, 61 . Second, probes/genes were clustered using the flashClust 25 implementation of a hierarchical clustering procedure with complete linkage and (1 -bicor) as a distance measure. Third, the resulting dendrogram was cut at a series of heights corresponding to the top 0.01%, 0.1%, 1%, 2%, 3%, 4%, or 5% of pairwise correlations for the entire data set. Moreover, for each of these thresholds, we modified the minimum module size to require 8, 10, 12, 15, or 20 members. This approach yielded 7 × 5 = 35 different gene coexpression networks for each regional data set. Third, initial modules in each network were summarized by their module eigengenes, defined as the first principal component obtained by singular-value decomposition of the coexpression module 24 . Fourth, highly similar modules were merged if the correlations of their module eigengenes exceeded an arbitrary threshold (0.85). This procedure was performed iteratively for each network, such that the pair of modules with the highest correlation (> 0.85) was merged first, followed by recalculation of module eigengenes, followed by recalculation of all correlations, until no pairs of modules exceeded the threshold. The WGCNA measure of intramodular connectivity (k ME ) was then calculated for each probe/gene with respect to all modules by correlating its expression pattern across all samples with each module eigengene 16, 24 .
Module enrichment analysis with cell-class-specific gene sets. To identify cell-classspecific gene coexpression modules in each regional data set, we cross-referenced module composition with gene sets consisting of published markers of major cell classes. For astrocytes, oligodendrocytes, and neurons, we used sets of genes that were expressed > 10× higher in each cell class (purified from mouse forebrain) vs. the other two (Supplementary Tables 4-6 from Cahoy et al. 22 ; n = 184 astrocyte genes, 130 oligodendrocyte genes, 319 neuron genes). For microglia, we used a set of genes expressed significantly higher in purified mouse microglia vs. whole brain (Supplementary Table 2 from Hickman et al. 23 ; n = 99 genes). For mural and ependymal cells, we used gene sets from adult mouse forebrain single-cell RNA-seq data (Supplementary Table 1 from Zeisel et al. 62 ; n = 155 mural genes, 484 ependymal genes). For endothelial cells, we used a set of genes that was significantly associated with known endothelial markers across 32 human organs (Supplementary Table 3 , tab 1, from Butler et al. 63 ; n = 237 genes). For OPCs, we used a set of genes identified in developing human midbrain single-cell RNA-seq data (Supplementary Table 1 from La Manno et al. 64 ; n = 48 genes). For choroid plexus cells, we used a set of genes from the Allen Mouse Brain Atlas (Supplementary Table 1 from Lein et al. 38 ; n = 101 genes). For Purkinje neurons, we used a set of genes identified from human cerebellar samples (Supplementary Table 6 from Kuhn et al. 65 ; n = 80 genes). For dopaminergic and cholinergic neurons, we created sets of genes based on the top 50 genes ranked by correlation to TH and CHAT in our human midbrain and striatum expression datas ets, respectively. Modules were defined as all unique genes with positive k ME values that were significant after applying a Bonferroni correction for multiple comparisons (P < 0.05 divided by the number of probes or genes in the regional data set × the number of modules in the network). If a probe/gene was significantly correlated with more than one module, it was assigned to the module for which it had the highest k ME value. For each regional data set, enrichment analysis was performed for all modules in all (n = 35) networks using a one-sided Fisher's exact test as implemented by the fisher.test R function. The module with the most significant enrichment for each cell-class gene set was identified in each regional data set.
Data integration and calculation of gene expression fidelity.
Operationally, we define the transcriptional 'profile' of a cell class in a given data set as a list of probes/genes ranked by descending k ME values for the most significant cellclass module. To create 'consensus' transcriptional profiles for each cell class, transcriptional profiles from individual data sets were combined using the following approach. First, data sets that did not contain a module significantly enriched with markers of a given cell class after applying a Bonferroni correction for multiple comparisons (P < 0.05 divided by the number of modules) were excluded (Supplementary Table 2 ). To reduce colinearity among endothelial, mural, choroid plexus, and ependymal cell-class signatures, we further pruned regional data sets in which a given cell-class module also showed significant enrichment for any other cell-class module. For dopaminergic neurons, fidelity calculations were restricted to midbrain data sets. Second, probe/gene identifiers from all data sets were mapped to a common identifier (HomoloGene ID data build 68). Third, k ME vectors for each cell-class module in microarray data sets (in which individual transcripts are often targeted by multiple probes) were collapsed to unique identifiers by retaining for each HomoloGene ID the probe with the highest k ME value. Because k ME values are correlation coefficients, they cannot be averaged directly over independent data sets of different sample sizes. Therefore, to aggregate cell-class-specific k ME values for a given HomoloGene ID across regional data sets, we used Fisher's method for combining correlation coefficients from independent data sets 66 . We implemented this method by initially transforming k ME values using the Fisher transformation: where n denotes the number of samples in data set d. The sampling s.d. of zgc is:
Dividing the 'average' z-scores by the sampling s.d. yielded the genome-wide statistics displayed in Figs. 2a-d and 4, Supplementary Figs. 6 and 11a-d Table 3 ) and mice (Supplementary Table 7 ). It is important to note that gene expression fidelity, as defined here, is robust to the choice of gene set used for enrichment analysis, as illustrated in Supplementary Fig. 2 .
Calculation of gene expression fidelity in distinct CNS regions.
We calculated gene expression fidelity in individual CNS regions represented by at least three independent data sets (FCX, STR, HIP, DI, and MID), as described above. We only included regional data sets that contained a significant cell-class module, as defined above.
Enrichment analysis of high-fidelity genes. The following gene sets were used to demonstrate that high-fidelity genes were significantly and specifically enriched (one-sided Fisher's exact test) with expected cell-class markers from multiple independent studies: Fig. 4 (A1 Visualization of core cell-class genes and their characteristics. The top 50 genes ranked by expression fidelity for each cell class were visualized with custom software using the ggplot2 package 71 in R (Fig. 3a-d and Supplementary  Fig. 11e-h) . Mean gene expression levels were calculated for all samples in each regional data set, converted to percentile ranks, and averaged across data sets ('CNS expression'). Regional percentile ranks (used in the analysis presented in Fig. 7) were similarly calculated for all samples from a given CNS region using ABI, GSE46706, and GTEx data sets. PubMed citations were extracted for each gene symbol using the RISmed package in R on 27 October 2016. To obtain total citations with potential relevance to specific cell classes we queried '[gene symbol]' and 'cell class' (for example, 'neuron'). Cellular localization data were extracted from the COMPARTMENTS resource 36 . Human protein-protein interaction (PPI) data were downloaded from the STRING database (file: 9606.protein.links. detailed.v10.txt) 37 . PPI links in Fig. 3 represent STRING combined score values > 350, which correspond to medium-confidence PPI predictions. Empirical P values for over-representation of putative protein interactions (PPI score > 350) among the top 50 cell-class genes were calculated from n = 100,000 permutations of 50 randomly sampled genes from a background of 18,451 HomoloGene identifiers (IDs present in at least one regional data set). Visualizations were similarly made for the top 50 mouse cell-class genes ranked by expression fidelity ( Supplementary  Fig. 11 ), except that PubMed citations were extracted on 28 December 2016 and the following STRING database file was used: 10090.protein.links.detailed.v10.txt.
Single-cell (SC)/single-nucleus (SN) RNA-sequencing analysis.
We obtained publicly available SC and SN RNA-seq data from four studies of adult human and mouse brains 1, 4, 26, 34 . Count data and sample information were downloaded from GEO using the accession IDs provided in Supplementary Table 1 . The SC data set from Darmanis et al. 1 consisted of 332 cells isolated from temporal cortices of 8 individuals undergoing surgery for epilepsy, while the SC data set from Tasic et al. 26 consisted of 1,375 'core' cells isolated from primary visual cortices of various transgenic mice (see Supplementary Data Table 3 from Tasic et al. 26 ). The SN data set from Lake et al. 34 Cell-class module eigengenes predict relative cellular abundance. To test the ability of cell-class module eigengenes to predict variation in cellular abundance, we analyzed gene coexpression relationships in synthetic mixtures of single-cell RNA-seq data from human 1 and mouse 26 brain. For the human data, counts were normalized by dividing the total number of reads for each gene by the total number of reads for the sample. Normalized data were then multiplied by one million to yield counts per million (CPM), increased by 1, and log 10 -transformed. For the mouse data, RPKM was used. We created synthetic mixtures by summing single-cell expression data over all genes from randomly sampled combinations of astrocytes, oligodendrocytes, microglia, and neurons. Each synthetic sample consisted of 16 or 22 total cells for the human and mouse data, respectively, which was based on the minimum number of unique cells that were available for any cell class (in both cases, microglia). We generated 100 synthetic samples and performed gene coexpression analysis and cell-class module detection as described above.
We chose a sample size of n = 100 for the synthetic tissue sample coexpression analysis to best match the sample sizes of our acquired human regional data sets. We repeated this process 10 times. For each iteration, estimates of relative cellular abundance were determined from cell-class module eigengenes (that is, PC1 of the most significant cell-class modules).
In principle, the ability of cell-class module eigengenes to estimate relative cellular abundance across conditions (for example, control samples versus Alzheimer's disease samples) could be confounded by concordant changes in the expression levels of high-fidelity genes used to estimate cellular abundance. For example, given two conditions, if the expression levels of high-fidelity genes uniformly increase in one condition but not the other, it could appear that the relative cellular abundance had changed when it had not. To estimate the fraction of high-fidelity genes that would need to concordantly change to confound estimates of cellular abundance, we performed a simulation study of synthetic samples. Specifically, we created a 'control' data set and a 'condition' data set, each consisting of 100 synthetic samples, by aggregating single-cell RNA-seq data from human brain 1 as described above. To construct module eigengenes, we identified the top 10 astrocyte, oligodendrocyte, microglia, and neuron genes via differential expression analysis (see below) that were also expressed in at least 50% of cells in their respective cell class. We systematically perturbed gene expression in the 'condition' data set by increasing the expression of randomly selected sets of genes (that is, by selecting 1-10 of the top 10 genes to perturb) by 100-, 50-, 25-, 10-, 5-, or two-fold for each cell class of interest. We then combined the synthetic condition data with the synthetic control data and calculated module eigengenes. We repeated this analysis a total of 10 times. We then compared these perturbed module eigengenes to the actual cellular abundance. As shown in Supplementary  Fig. 9 , these perturbations had little effect on cell-class composition estimates across a wide range of expression level changes, as long as at least half of the genes used to calculate the eigengenes remain unaltered.
Gene coexpression analysis predicts differential expression among CNS cell classes.
To test the relationship between cell-class module membership (k ME ) and differential expression, we calculated differential expression statistics from SC RNA-seq data using Monocle v2.2.0 72 . Restricting our analysis to exactly the same cells that were used to construct each synthetic data set (described above), we calculated genome-wide differential-expression statistics for each cell class compared to all other cell classes. Because the Monocle output statistics do not indicate directionality (that is, up-or downregulation), we ordered genes based on P value and fold-change. Therefore, genes with the highest differential expression percentile are the most significantly upregulated in a given cell class, and vice versa. Figure 1 and Supplementary Fig. 1 compare k ME values from synthetic cellclass modules with differential expression percentiles for the corresponding cell class (averages of 10 iterations).
Comparing gene expression fidelity with adult human SN RNA-seq data. To further examine the relationship between estimates of gene expression fidelity from intact tissue samples and estimates of differential expression among single cells, we calculated differential expression statistics from SN RNA-seq data for astrocytes, oligodendrocytes, microglia, and neurons, using the cell assignments provided by the authors of the original studies 4, 34 . We used count data as input and calculated the significance of differential expression using Monocle v2.2.0 72 , ordering genes based on P value and fold-change, as described above. Data sets were merged using HGNC gene symbol identifiers. To compare discordant results between fidelity and SN RNA-seq with orthogonal data (Fig. 2n-q) , we analyzed RNA-seq data for cell classes that were purified by immunopanning from human temporal lobe surgical resections 3 (FPKM data from GEO; see Supplementary Table 1 ). For each cell class (astrocytes, microglia, neurons, and mature (that is, not O4+ ) oligodendrocytes), we averaged the expression values across replicate samples. To calculate the 'proportion of transcripts' for a given gene and cell class ( Fig. 2n-q) , we divided the average expression value for that gene in a particular cell class by the sum of its average expression values for all cell classes.
Modeling gene expression in the human CNS. Modeling gene expression in the neurotypical CNS.
To determine how much of the variation in human CNS transcriptomes can be explained by variation in the abundance of major cell classes, we performed multiple linear regression of gene expression (γ s ) in each regional data set composed of s samples using the lm function in R: where a cs represents the inferred abundance in sample s of cell class c (where c = astrocyte, oligodendrocyte, microglia, or neuron), β c is the regression coefficient for cell class c, β 0 is a constant, and ε s is the error term. a cs was estimated for each cell class using high-fidelity genes. Specifically, we calculated the first principal component (PC1) of the expression matrix for the top x high-fidelity genes (where x = 10 unless otherwise stated) over all samples in each regional data set. PC1 was obtained through singular value decomposition of the scaled expression data using the svd (nu = 1, nv = 1) function in R, which is identical to the module eigengene metric 24 . When obtained in this fashion, PC1 of high-fidelity genes is a good predictor that is robust even when x is small (Fig. 5b) .
To standardize modeling across data sets, we restricted our analysis to regional human CNS data sets with at least 40 samples (n = 47; Supplementary Table 1 ). We restricted modeling to data sets with 40 samples to provide ~85% power to identify large effect sizes (f 2 > 0.4; P < 0.05) when testing the hypothesis that the proportion of gene expression variance explained by variation in the abundance of the four cell classes is zero. We performed gene expression modeling for ~9,600 genes that mapped to HomoloGene IDs that were present in all 47 dat asets. If multiple probes mapped to a given HomoloGene ID, we retained the probe with the highest mean expression in the subset expression data. For each data set, we randomly selected ten sets of 40 samples for gene expression modeling and averaged the adjusted r 2 values from the ~9,600 gene expression models for the ten random subsets. We report adjusted r 2 values because they facilitate comparisons of models with different numbers of parameters 73 . To avoid circularity in gene expression modeling, we redefined consensus cell-class signatures using a leaveone-out approach. Specifically, we calculated gene expression fidelity for each cell class as described above using 46 data sets, then used the resulting high-fidelity genes to infer cellular abundance and model gene expression in the 47th data set (as illustrated in Fig. 5a-c) . This procedure was performed iteratively for all 47 data sets. In all cases, genes that were used to infer cellular abundance were excluded from gene expression modeling. For example, if the top ten high-fidelity genes were used to infer cellular abundance, those ten genes were excluded from modeling to avoid circularity. Therefore, the total number of modeled genes depends on the total number of genes used to infer cellular abundance (that is 1, 10, or 50 genes, as illustrated in Fig. 5b) .
To further demonstrate the robustness of gene expression modeling as a function of inferred cellular abundance, we replicated the results shown in Fig. 5b after redefining consensus cell-class signatures using a leave-x-out approach, where x corresponded to 10, 20, 40, 60, 80, or 90% of data sets, which were sampled at random (n = 10 iterations per value of x). Subsequent analysis and modeling was performed as described above. As shown in Supplementary Fig. 7 , gene expression modeling results were nearly identical for all values of x. These findings highlight the robust nature of gene expression fidelity, the resulting estimates of variation in cellular abundance, and the ensuing predictions of gene expression levels as a function of cellular composition in intact tissue samples. Furthermore, we did not observe consistent colinearity of estimated cellular abundance across data sets, with the exception of oligodendrocytes and microglia, which tended to exhibit moderate positive correlations (~0.4) due to the increased concentration of these cells in white matter versus gray matter 46 . However, this relationship did not preclude the identification of high-fidelity genes for each cell class.
Modeling gene expression in Alzheimer's disease (AD) brain samples.
Publicly available gene expression data from AD and control samples from three additional data sets (GSE48350, GSE44770, and GSE36980) [40] [41] [42] were downloaded from GEO and preprocessed using the SampleNetwork R function 55 to identify sample outliers. We defined sample outliers as those that were more than 3 s.d. below the mean connectivity of all samples measured over all features (Z.K < -3). Iterative pruning was applied until all samples with Z.K < -3 were removed.
For GSE44770 gene expression data, which were acquired with a Rosetta Human 44k microarray platform, we focused our analysis on the dorsolateral prefrontal cortex (PFC) samples, which were found in the original publication to have more transcriptional changes associated with AD compared to visual cortex and cerebellum 41 . Starting with the raw CY5 probe intensity values, we performed imputation of missing values 74 , quantile normalization 57 , and batch correction 56 . We removed 20 sample outliers from 230 PFC samples. Batch correction was performed using batch information provided in the original study.
For GSE48350 gene expression data, which were acquired with an Affymetrix U133 plus 2.0 microarray platform, normalization was performed using the RMA algorithm 50 with the justRMA function of the affy R package and reverse log-transformed for further processing. We removed 4 sample outliers out of 253 samples. Batch correction was performed 56 using the hybridization batch date extracted from the .CEL file header information. For GSE36980 gene expression data, which were acquired with an Affymetrix Gene 1.0 ST microarray platform, normalization was performed using the RMA algorithm 50 with the justRMA function of the affy R package 53 and reverse log-transformed for further processing. Due to small sample size (n = 79 samples), we did not remove any sample outliers.
To estimate relative cellular abundance in control and AD samples ( Fig. 6e and Supplementary Fig. 8a,b) we calculated module eigengenes (PC1 obtained by singular-value decomposition) using microarray probes that matched our consensus top 10 high-fidelity genes for each cell class. When multiple probes matched a high-fidelity gene, we retained the probe with the highest correlation to other high-fidelity genes. Module eigengenes were calculated from the combined expression data of control and AD samples, which were jointly normalized as described above.
We performed gene expression modeling in these data sets for every probe using the top 10 high-fidelity genes for each cell class as described above. For transcripts of high-fidelity genes that were targeted by multiple microarray probes, we retained the probe with the highest adjusted r 2 value when modeled as a function of the inferred relative abundance of astrocytes, oligodendrocytes, microglia, and neurons.
Gene expression modeling was performed separately for control and AD samples. We ensured that the number of samples and regions sampled were matched between AD and control samples. For GSE44770, which contained more AD samples than control samples, we took a random subset of AD samples to match the number of control samples (95 of 112). For GSE48350, we first filtered the control samples to donors ≥ 70 years old to match the ages of the AD and control samples, which gave 71 control and 79 AD samples. We subsequently took a random subset of the AD samples, attempting to match the region of the samples (16 of 24 postcentral gyrus samples), which gave 14 control and 15 AD entorhinal cortex samples, 20 control and 19 AD hippocampus samples, 17 control and 16 AD postcentral gyrus samples, and 20 control and 21 AD superior frontal gyrus samples. For GSE36980, we first filtered the control samples to donors ≥ 75 years old to match the ages of the AD and control samples, which gave 35 control and 32 AD samples. We subsequently took a random subset of the control samples, attempting to match the regions of the samples (10 of 12 temporal cortex samples), which gave 15 control and 15 AD frontal cortex samples, 7 control and 7 AD hippocampus samples, and 10 control and 10 AD temporal cortex samples.
To identify genes that were differentially expressed between control and AD after controlling for variation in cellular abundance, we calculated the differences in t statistics for cell-class model coefficients in control and AD data sets. We then randomly split each data set (using the sample subsets above) into two equal-sized groups of samples (such that each half included control and AD samples) and performed gene expression modeling for each half (n = 1,000 permutations). For each permutation, we calculated the differences in t statistics for cell-class model coefficients of the two randomly separated groups, which produced a null distribution of t-statistic differences for each cell-class parameter and each gene. Using the null distributions for each gene, we calculated empirical P values for the measured t-statistic differences between control and AD gene models. Genes were considered differentially expressed in a given cell class between control and AD if the resulting P values were < 0.05 in each of the three independent data sets.
We note that in principle, the interpretation of modeling results can be confounded by concordant changes in cellular abundance and the expression levels of high-fidelity genes that are used to estimate cellular abundance. Simulation studies suggest that such a scenario is unlikely to occur unless more than half of the genes used to calculate an eigengene are transcriptionally dysregulated ( Supplementary Fig. 9 ). In practice, this possibility can be mitigated by comparing estimates of cellular abundance derived from different groups of high-fidelity genes, or by including a sufficiently large number of high-fidelity genes (for example, 50) such that up-or downregulation of any individual gene (or several genes) is unlikely to have an effect on estimates of cellular abundance.
Below we present example R code for resolving changes in cellular composition from changes in cell-class-specific transcriptional identity: #Example illustrating how to identify cell-classspecific expression changes in intact tissue samples while controlling for differences in cellular composition: #Load expression data. In this example rows are genes and columns are samples. Control samples are the first 100 columns (1:100) and condition samples are the second 100 columns (101:200): datExpr= read.table("data.csv") #Create cell-class module eigengenes (i.e. relative cellular abundance estimates). #Subset to cell-class genes of interest with a subset vector: cell.expr= datExpr[subset,] #Standardize expression values for each gene: cell.expr= t(scale(t(cell.expr))) #Calculate module eigengene (ME, aka relative cellular abundance) using singular value decomposition: ME= svd(cell.expr,nu= 1,nv= 1)$v[,1] #To ensure positive module eigengene values correspond to higher expression levels, we assess the correlation with ME and gene expression of a cell-class gene:if (cor(NME,as.numeric(datExpr[is.element(rownames(datExpr ),subset [1] ),]))< 0){ME= -1*ME} #To determine if relative cellular abundance is significantly altered between the conditions: Condition= c(rep("ctrl",100),rep("cond",100)) wilcox.test(ME~Condition,data= tmp)$p.value #To determine if a gene is differentially expressed between sample cohorts after controlling for differences in relative cellular abundance, we perform linear modeling in each condition with ME as the predictor: #Recalculate MEs separately for each condition: ME.ctrl= svd(t(scale(t(datExpr[is.element(rownames (datExpr),subset),1:100]))))$v[,1] ME.cond= svd(t(scale(t(datExpr[is.element(rownames (datExpr),subset),101:200]))))$v[,1] #Subset to gene of interest for each condition: ctrl= datExpr[gene.subset,1:100] cond= datExpr[gene.subset,101:200] #Calculate modeling t-value for each condition: ctrl.tvalue= summary(lm(as.numeric(ctrl)~ME. ctrl))$coef [2, 3] cond.tvalue= summary(lm(as.numeric(cond)~ME. cond))$coef [2, 3] #To determine the significance of the t-value difference between condition and control, one can perform a permutation analysis of randomly sampled 'control' and 'condition' datasets, using example code above, to calculate an empirical p-value.
Modeling gene expression to identify regional differences in transcriptional identities of major cell classes. To explore the regional heterogeneity of gene expression in major CNS cell classes, we adopted a conservative strategy to identify genes with binary expression patterns (that is, ON in a given cell class in one region but OFF in the same cell class in another region). To reduce technical confounds, we restricted our analysis to pairwise comparisons of five brain regions (DI, FCX, HIP, MID, and STR) that were transcriptionally profiled in three independent studies (GTEx, GSE46707, and ABI). For each of these regional data sets (n = 15), we performed gene expression modeling as described above for all genes and samples using the top 10 high-fidelity genes to infer the relative abundance of each cell class. A gene was considered to be 'regionally expressed' in a specific cell class if it met the following criteria: (i) it was significantly associated with the cell class in region 1 (P < 2.67 × 10 −8 , corresponding to a Bonferroni-corrected P value for the cell-class model coefficient based on the total number of gene models: 0.05/([4 cell classes] × [5 regions] × [48,170 ABI probes + 17,868 GSE46706 genes + 27,526 GTEx genes])); (ii) it was not significantly associated with the same cell class in region 2; (iii) it was differentially expressed between region 1 and region 2 (that is, the mean expression percentile rank was > 20 percentile ranks higher in region 1 versus region 2; and (iv) the preceding criteria were replicated in all three studies.
Analysis of CNS transcriptomes from nonhuman species.
We obtained publicly available gene expression data from intact tissue samples of mouse, rhesus macaque, and chimpanzee brains ( Supplementary Table 1 ). Data preprocessing is described below.
Mouse brain expression data preprocessing, integration, and modeling. Mouse gene expression data were obtained from 22 studies 17, 22, 47, 67, [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] and one resource (http://www.genenetwork.org). Preprocessing was performed from raw data when possible. Affymetrix microarray raw data (.CEL files) were downloaded from GEO using the accession IDs provided in Supplementary Table 1 . We only processed wild-type samples from studies with multiple conditions. Expression values for Affymetrix 430A, 430 2.0, and 430A 2.0 microarray probes were generated in R using the expresso function of the affy R package 53 with 'mas' settings and no normalization. Probe-level data from Affymetrix Exon 1.0 and Gene 1.1 microarrays were summarized using the Robust Multi-Array (RMA) algorithm 50 at the gene level with Affymetrix Power Tools software (APT 1.15.2) and reverse log-transformed for further processing. Non-normalized Illumina microarray data were obtained from GEO. For RNA-seq data sets, FPKM gene expression values (Ms.Barres, Ms.Fertuzinhos, Ms.GSE63078) or count data (Ms.GSE60312, Ms.GSE62669) were downloaded from GEO or the study's website (Supplementary Table 1 ). We normalized raw count data from Ms.GSE60312 by dividing the total number of counts for each gene by the total number of counts for the sample.
Sample information for data sets with GEO accession IDs was obtained using the R package GEOquery 54 , with the exception of hybridization batch information, which was extracted from the header information of Affymetrix .CEL files when available. Each of the mouse data sets was individually processed using the SampleNetwork R function 55 , which is designed to identify and remove sample outliers, perform data normalization, and adjust for batch effects 56 . We defined sample outliers as those that were more than 4 s.d. below the mean connectivity of all samples measured over all features (Z.K < -4). Iterative pruning was applied to remove all samples with Z.K < -4. For non-normalized Affymetrix 430A, 430 2.0, 430A 2.0, and Illumina microarray data, quantile normalization 57 was then performed. If a batch effect was present (defined as a significant association between the first principal component of the expression data and a technical batch covariate), batch correction was performed using the ComBat R function 56 , which is implemented in SampleNetwork. See Supplementary Table 1 for the number of sample outliers removed and data sets that were batch corrected.
Mouse coexpression analysis, enrichment analysis to identify cell-class modules, and data integration to determine consensus gene expression fidelity for major cell classes were performed as described for human data, with one exception. Due to heterogeneity introduced by variable sample preparation methods for mouse data sets ( Supplementary Table 1 ), we iteratively pruned outlier data sets before consensus fidelity calculations. Specifically, for each cell class we performed hierarchical clustering of genome-wide k ME values for all data sets using (1 -Pearson correlation) as the distance measure, with average linkage. Data sets with distance > 0.9 were iteratively pruned. Data sets included in the consensus fidelity calculation are indicated in Supplementary Table 1 . Gene expression modeling was performed as described above using the top 10 genes from each mouse consensus expression fidelity cell-class list.
Human versus mouse comparison. We implemented a conservative strategy to identify cell-class-specific gene expression differences between humans and mice (that is, ON in a given cell class in humans but OFF in the same cell class in mice, or vice versa). To identify genes expressed in human but not mouse cell classes, we started with the sets of genes represented by the Venn diagram in Fig. 6a (that is, genes that were significantly associated with the same cell class in a majority of human regional data sets using a genome-wide, Bonferroni-corrected P value). We imposed three criteria to predict species differences: (i) the gene was consistently well modeled with respect to the same cell class in humans (human median adjusted r 2 ≥ 0.4); (ii) the gene was not well modeled with respect to the same cell class in mice (mouse median adjusted r 2 ≤ 0.05); (iii) the gene was expressed substantially more highly in humans versus mice (mean expression percentile difference > 30).
To identify genes expressed in mouse but not human cell classes, we started with mouse genes that were significantly associated with the same cell class in at least three independent data sets (using the same definition of 'significant association' that was used for humans). We imposed three criteria to predict species differences: (i) the gene was well modeled with respect to the same cell class in mice (mouse median adjusted r 2 ≥ 0.4); (ii) the gene was not well modeled with respect to the same cell class in humans (human median adjusted r 2 ≤ 0.05); (iii) the gene was expressed substantially more highly in mice versus humans (mean expression percentile difference > 30). Primate brain expression data preprocessing and modeling. Affymetrix gene expression data from chimpanzee cerebral cortex were obtained from eight studies. Four studies analyzed samples using Affymetrix U95A/v2 microarrays [93] [94] [95] [96] , and four studies analyzed samples using Affymetrix U133Plus2 microarrays [97] [98] [99] [100] . Because probes on these arrays were designed from human sequences, we created a custom mask file to exclude probes that did not have perfect alignment to the chimpanzee genome (panTro3: http://hgdownload.cse.ucsc.edu/goldenPath/ panTro3/bigZips/panTro3.fa.gz) and chimpanzee RefSeq mRNAs (http:// hgdownload.cse.ucsc.edu/goldenPath/panTro3/bigZips/refMrna.fa.gz). After excluding all unknown, random, haplotype, and mitochondrial sequences, the chimpanzee genome was concatenated into a single file. This file, along with the RefSeq mRNA file, was formatted for BLAST from the command line using the formatdb function from the ncbi_tools package (installed via MacPorts). Using a local BLAST installation, we retained a probe if it aligned perfectly to both the chimpanzee genome (e = 2.0 × 10 -5 ) and chimpanzee RefSeq mRNAs (e = 2.0 × 10 -8 ).
We also excluded probes that were identified as mistargeted or nonspecific with respect to human sequences based on a previous re-annotation study 52 . The resulting mask files (one for each microarray platform) were used with the ProbeFilter R package 51 to exclude probes without perfect and specific alignment to chimpanzee sequences.
Expression data were generated from masked .CEL files using the expresso function from the affy package with 'mas' settings and no normalization, followed by scaling each sample to the same mean intensity (200). Only probe sets with at least half of their probes remaining after mask application were retained for further analysis (n = 9,178 for U95A/v2; n = 35,754 for U133Plus2). Further quality control and preprocessing were performed with the SampleNetwork R function 55 . Samples from each study were examined separately and no outliers were evident. After combining all samples for a given platform, data were quantile-normalized 57 and batch-corrected for hybridization date using the ComBat R function 56 . The final, processed data sets consisted of 30 samples (U95A/v2) and 26 samples (U133Plus2) from chimpanzee cerebral cortex. RNA-seq RPKM gene expression data 45 from chimpanzee brain were downloaded from GEO (GSE49379). Further quality control and preprocessing were performed with the SampleNetwork R function 55 . No outliers were evident.
Affymetrix Macaque genome array normalized expression data 20,101 from ABI were downloaded from http://www.blueprintnhpatlas.org (6 March 2014 data release). Further quality control and preprocessing were performed with the SampleNetwork R function 55 . We defined sample outliers as those that were more than 4 s.d. below the mean connectivity of all samples (Z.K < -4) measured over all features. Iterative pruning was applied to remove all samples with Z.K < -4. See Supplementary Table 1 for the number of sample outliers removed.
Due to the limited availability of gene expression data from nonhuman primate (NHP) brains, we did not attempt to calculate consensus gene expression fidelity statistics. Instead, we used a semisupervised approach to identify top cell-class biomarkers for gene expression modeling in NHP brain samples. Parsimony and similarities between human and mouse gene expression fidelity suggested that there was likely to be strong conservation of high-fidelity genes between human and NHP CNS cell classes. To determine the microarray probes that best matched our high-fidelity human genes in NHP expression data, we took a three-step approach: (i) we identified NHP probes that targeted the top 50 high-fidelity genes for each human cell class; (ii) we calculated the Pearson correlations among these probes over all NHP samples for each data set; (iii) we identified the top 10 probes with the highest average correlations to the others that mapped to unique gene symbols. These top 10 probes (genes) were summarized by PC1 through singular value decomposition of the scaled expression data using the svd (nu = 1, nv = 1) function in R, and PC1 was used for estimating the relative abundance of each NHP cell class in gene expression modeling.
Gene Ontology and pathway enrichment analysis. The ToppGene (https:// toppgene.cchmc.org/) suite 102 contains an extensive list of databases and was used to calculate enrichment P values from hypergeometric tests corrected for multiple comparisons. Specifically, we used the ToppFun application with default parameters and report Benjamini-Hochberg-adjusted P values. We present data from Gene Ontology (GO) annotations (biological process, cellular component, and molecular function) and pathway annotations (Biosystems, BIOCYC, KEGG, and REACTOME).
For disease annotations (Fig. 6b) , we used the Phenopedia database 39 , which is a curated collection of records retrieved weekly from an automatic literature screening program 103 of PubMed abstracts for gene-disease associations. Staff at NCBI manually select abstracts that meet inclusion criteria. We analyzed enrichment of our human cell-class genes (Fig. 6a ) with disease annotations consisting of ≥ 10 genes using a one-sided Fisher's exact test as implemented in the fisher.test R function. These P values were corrected for multiple comparisons by controlling for the false-discovery rate, as implemented by the R package qvalue 49 . Hierarchical clustering of the log-transformed P values was performed using Pearson's correlation as the similarity metric and average linkage. Phenopedia data were accessed on 14 December 2015.
Immunohistochemistry. Human brain tissue was collected during autopsy with postmortem interval < 48 h. Tissue was collected with previous patient consent in strict observance of legal and institutional ethical regulations in accordance with the University of California San Francisco Committee on Human Research. Brains were cut into ~1.5-cm coronal or sagittal blocks, fixed in 4% paraformaldehyde for 2 d, cryoprotected in a 30% sucrose solution, and embedded in optimal cutting temperature (OCT) compound (Tissue-Tek). Samples contained no evidence of brain disease as assessed by a neuropathologist (E.J. Huang). We collected 14-μ m cryosections on Superfrost slides (VWR) using a Leica CM3050S cryostat. Cryosections were subjected to heat-induced antigen retrieval in 10 mM sodium citrate (pH = 6) for 10 min and permeabilized and blocked for 1 h at room temperature in PBS supplemented with 0.2% Triton X-100 and 10% goat serum. Primary incubations were overnight at 4 °C. Washes (3 × 10 min) and secondary incubations (1 h) were performed at room temperature (20-25 °C) .
We searched for high-fidelity genes in the Human Protein Atlas 104 and identified validated antibodies for PON2 (astrocytes), DBNDD2 (oligodendrocytes), APBB1IP (microglia), and CELF2 (neurons; Fig. 3a-d) . Antibodies used included goat PON2 (R&D systems: AF4344, 1:200), mouse ALDH1L1 (Neuromab: 73-140, 1:200), rabbit DBNDD2 (Sigma: HPA043991, 1:200), rabbit APBB1IP (Sigma: HPA017009, 1:100), rabbit CELF2 (Sigma: HPA035813, 1:200), rat GFAP (Fisher: 13-0300, 1:500), mouse NogoA (11c7; gift from M. Schwab, Zurich, Switzerland, 1:5,000), goat AIF1 (Abcam: ab5076, 1:500), chicken NeuN (Millipore: ABN91, 1:500), rabbit PMP2 (Proteintech: 12717-1-AP, 1:100), chicken V5 (Abcam: AB9113, 1:500), chicken RFP (Rockland: 600-901-379S, 1:1,000), rabbit DsRed (Clontech: 632496, 1:500), and chicken GFP (Aves: GFP-1020, 1:500).
Images were acquired on a Leica TCS SPE laser confocal microscope with detection settings normalized to a secondary-only control. For IHC data (Fig. 3e-h and Supplementary Fig. 5 ), a 20× objective was used (1,024 × 1,024 pixels).
Fluorescent in situ hybridization (FISH). Human brain tissue was acquired as described above. All mouse strains were maintained in the University of California San Francisco specific-pathogen-free animal facility, and all animal protocols were approved by and in accordance with the guidelines established by the Institutional Animal Care and Use Committee and Laboratory Animal Resource Center. Mouse brain tissue (postnatal day 30) was acquired from animals perfused with 4% PFA and postfixed for 24 h, followed by cryoprotection in 30% sucrose, after which tissue was embedded in OCT. Cryosections were prepared in the same manner described above.
Due to variability in RNA quality from human brain cases, we screened a number of samples for robust positive RNA signal using the RNAscope 2.0 HD brown assay (Advanced Cell Diagnostics, Hayward, CA; catalog #310033) for PPIB, a positive control. A sample from occipital cortex of a 19-month-old patient demonstrated positive signal and was subsequently used for RNAscope multiplex fluorescent imaging (catalog #320851) of candidate species differences in astrocyte expression ( Supplementary Fig. 12c,d) , according to the manufacturer's instructions. RNAscope probe information is in Supplementary Table 9 .
Images were acquired on a Leica TCS SPE laser confocal microscope with detection settings normalized to a negative control probe (DapB, catalog: 310043). A 40× objective was used (1,024 × 1,024 pixels). Images shown in Fig. 7 and Supplementary Fig. 12 were processed using the spots function (with default parameters) in the imaging software program Imaris (Bitplane).
PMP2 ectopic expression. All mice were maintained in the University of California San Francisco specific-pathogen-free animal facility, and all animal protocols were approved by and in accordance with the guidelines established by the Institutional Animal Care and Use Committee and Laboratory Animal Resource Center. Swiss Webster mice were used in all viral experiments (Simonsen Laboratories, Gilroy, CA). For AAV-PMP2 ectopic expression, two females and two males were used in each group. For lentiviral-PMP2 ectopic expression, three females and one male were used in each group. Otherwise, male mice were used. Animals were randomly allocated into experimental groups. No statistical methods were used to predetermine sample sizes, but our sample sizes are similar to those reported in previous publications. Data collection and analysis were not performed blind to the conditions of the experiments, as co-staining with PMP2 allowed the experimenter to deduce the experimental groups. To generate adeno-associated virus (AAV), we subcloned the human PMP2 transcript (NM_002677.4) into an AAV plasmid backbone containing a GFAP minimal promoter (gfaABC1D) and tdTomato reporter. The AAV backbone was obtained from Addgene (pZac2.1 gfaABC1D-tdTomato, catalog # 44332) and Cyagen performed the subcloning. PMP2 was subcloned upstream of tdTomato and separated by a t2A self-cleaving peptide allowing for bicistronic expression (Fig. 8g ). Control (gfaABC1d-tdTomato) and PMP2 (gfaABC1d-PMP2-t2A-tdTomato) AAV5 viruses were generated by the Penn Vector Core (1.03 × 10 14 and 2.096 × 10 13 genome copies per mL, respectively). To generate lentivirus, the human PMP2 transcript (NM_002677.4) was synthesized with a 3′ t2A self-cleaving peptide by GenScript. This transcript was subcloned into a third-generation lentivirus backbone that contained a GFAP minimal promoter (gfaABC1D), spaghetti monster (sm) V5-tag reporter 105 , and a Lck membrane-targeting domain. The plasmid was a generous gift from A. Gleichman (Carmichael lab, UCLA). PMP2 was subcloned upstream of smV5 and separated by a t2A self-cleaving peptide ( Supplementary Fig. 12f ). High-concentration lentivirus was created by the UCSF viral core (~10 8 colonyforming units per mL) for control (gfaABC1D-Lck-SmV5) and PMP2 (gfaABC1D-PMP2-t2A-Lck-SmV5) viruses.
To infect mouse astrocytes in vivo, 1 μ L of virus (for AAV experiments, the control vector was diluted 1:5 in PBS) was injected into the lateral ventricles of postnatal day 1 mice (coordinates from lambda: x = 0.8 mm lateral, y = 1.5 mm caudal, z = -1.6 mm from surface). Forty-two days after injection, mice were killed by perfusion (as above) for histological analysis. Thick sections were created using a sliding microtome (Microm HM 450; 140 μ m and 50 μ m for the AAV and lentivirus experiments, respectively). After staining for V5 or tdTomato (see antibodies above), astrocytes were imaged with a confocal microscope (CSU-W1 spinning disk or Leica TCS SPE for AAV and lentivirus experiments, respectively) at 40× and ~0.3-μ m step size. The maximum astrocyte diameter was defined as the greatest linear distance between two points in a two-dimensional slice that crossed through the nucleus. Primary branches were counted manually through the z-stacked images.
Website information. Genome-wide estimates of expression fidelity for CNS cell classes are provided in Supplementary Table 3 for humans and Supplementary  Table 7 for mice. To facilitate interactions with our findings, we also created a website where users can search by CNS region, cell class, and gene to retrieve information about gene expression fidelity and associated measures (http:// oldhamlab.ctec.ucsf.edu/). Major CNS cell classes (astrocytes, oligodendrocytes, microglia, and neurons) are currently supported.
Statistics and data presentation. All statistical analyses were performed in the R statistical computing environment (http://cran.us.r-project.org). Fisher's exact test was used to assess the significance of gene set enrichment, and Wilcoxon signed-rank and rank-sum tests were used to assess the significance of median differences (for paired and unpaired data, respectively). For PMP2 experiments, the normality of the data was verified using the Shapiro-Wilk test, and unpaired one-sided Welch's t tests were used to assess the significance of mean differences between the two groups. Linear regression was used to assess the predictive significance of cellular abundance with respect to gene expression patterns. The following assumptions were made: linear relationship between dependent and independent variables, normality of the variables, little multicolinearity between the independent variables, statistical independence of the residuals, and homoscedasticity (that is, constant variance of the residuals). These assumptions were not formally tested for all models (that is, all genes). However, scatter plots of select models (for example, Figs. 6c,g, 7j , and 8c; Supplementary Figs. 8, 10 , and 12; and others not shown) suggest that these assumptions are valid. Violin plots outline the Gaussian kernel probability density and are trimmed to the range of the data. Edges of boxplots denote interquartile ranges (25th-75th percentile) with whiskers denoting 1.5 times the interquartile range and black line denoting the median value; notches denote 1.58 times the interquartile range divided by the square root of the number of samples. 
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Data collection
Leica software (LAS X) was used for histology image acquisition.
Data analysis
Bioinformatics and statistical analyses were performed in R v3.1.1. The following R packages were implemented as described in the methods: ProbeFilter, expresso, affy, GEOquery, SampleNetwork, ComBat, WGCNA, ggplot2, RISmed, Monocle2, ncbi_tools. Affymetrix Power Tools (APT 1.15.2) was used for processing Affymetrix microarrays as described in the methods. Imaris v8 was used for image analysis.
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Sample size
We chose a sample size of n = 100 for the synthetic tissue sample coexpression analysis (Figs. 1, S1, S9) to best match the sample sizes of our acquired human regional datasets. We restricted modeling to datasets with 40 samples (Figs. 5. S7) to provide ~85% power to identify large effect sizes (f 2 > 0.4, P < .05) when testing the hypothesis that the proportion of gene expression variance explained by variation in the abundance of four cell types is zero. For biological validation experiments, no statistical methods were used to pre-determine sample sizes but our sample sizes are similar to those reported in previous publications (e.g. Stogsdill et al. Nature 2017).
Data exclusions
We performed stringent quality control on each transcriptomic dataset using consistent criteria and published methods, resulting in the exclusion of low-quality samples (see Methods). Using pre-established criteria, we defined sample outliers as those that were more than four standard deviations below the mean connectivity of all samples measured over all features (Z.K < -4). As this process was done iteratively, we chose this threshold to remove large outliers while maximizing sample size.
Replication
Transcriptomic analyses were extensively replicated across distinct datasets and technology platforms (e.g. two-independent datasets for the single-cell analysis; data-integration from eight published studies for human consensus profiles; leave-one-out cross validation over 47 datasets for the modeling results; three-independent datasets for the Alzheimer's disease analysis; three-independent datasets for the regional analysis; data-integration over at least 10 mouse datasets, two macaque datasets, and three chimpanzee datasets). Histology was validated by at least two replications. Viral experiments were repeated and validated with a separate animal cohort and viral strategy.
Randomization Animals were randomly allocated into experimental groups.
Blinding
For viral experiments, investigators were not blind to group allocation during data collection or analysis. However, analysis was performed separately by two independent investigators. Blinding was difficult to do in this experiment as simultaneous co-staining for PMP2 made it possible for the experimenter to discern experimental groups.
Reporting for specific materials, systems and methods 
